RT Journal Article
SR Electronic
T1 Estimating and communicating prognosis in advanced neurologic disease
JF Neurology
JO Neurology
FD Lippincott Williams & Wilkins
SP 764
OP 772
DO 10.1212/WNL.0b013e318282509c
VO 80
IS 8
A1 Holloway, Robert G.
A1 Gramling, Robert
A1 Kelly, Adam G.
YR 2013
UL http://n.neurology.org/content/80/8/764.abstract
AB Prognosis can no longer be relegated behind diagnosis and therapy in high-quality neurologic care. High-stakes decisions that patients (or their surrogates) make often rest upon perceptions and beliefs about prognosis, many of which are poorly informed. The new science of prognostication—the estimating and communication “what to expect”—is in its infancy and the evidence base to support “best practices” is lacking. We propose a framework for formulating a prediction and communicating “what to expect” with patients, families, and surrogates in the context of common neurologic illnesses. Because neurologic disease affects function as much as survival, we specifically address 2 important prognostic questions: “How long?” and “How well?” We provide a summary of prognostic information and highlight key points when tailoring a prognosis for common neurologic diseases. We discuss the challenges of managing prognostic uncertainty, balancing hope and realism, and ways to effectively engage surrogate decision-makers. We also describe what is known about the nocebo effects and the self-fulfilling prophecy when communicating prognoses. There is an urgent need to establish research and educational priorities to build a credible evidence base to support best practices, improve communication skills, and optimize decision-making. Confronting the challenges of prognosis is necessary to fulfill the promise of delivering high-quality, patient-centered care.DNR=do not resuscitate